Newmark Group Chairman Howard Lutnick has been diagnosed with a treatable form of non-Hodgkin lymphoma and will receive chemotherapy starting this week to fight the disease, according to a regulatory filing made Tuesday.
Newmark Says Its Chairman Is Battling ‘Highly Treatable’ Form of Cancer
Howard Lutnick, Also Chairman and CEO of Cantor Fitzgerald, Diagnosed With Non-Hodgkin Lymphoma
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In